{
  "DOI": "10.1016/j.ajhg.2019.04.017",
  "ISSN": [
    "0002-9297"
  ],
  "URL": "http://dx.doi.org/10.1016/j.ajhg.2019.04.017",
  "alternative-id": [
    "S000292971930165X"
  ],
  "assertion": [
    {
      "label": "This article is maintained by",
      "name": "publisher",
      "value": "Elsevier"
    },
    {
      "label": "Article Title",
      "name": "articletitle",
      "value": "Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity"
    },
    {
      "label": "Journal Title",
      "name": "journaltitle",
      "value": "The American Journal of Human Genetics"
    },
    {
      "label": "CrossRef DOI link to publisher maintained version",
      "name": "articlelink",
      "value": "https://doi.org/10.1016/j.ajhg.2019.04.017"
    },
    {
      "label": "Content Type",
      "name": "content_type",
      "value": "article"
    },
    {
      "label": "Copyright",
      "name": "copyright",
      "value": "© 2019 American Society of Human Genetics."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Fragoulakis",
      "given": "Vasileios",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Roncato",
      "given": "Rossana",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Fratte",
      "given": "Chiara Dalle",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ecca",
      "given": "Fabrizio",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bartsakoulia",
      "given": "Marina",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Innocenti",
      "given": "Federico",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Toffoli",
      "given": "Giuseppe",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Cecchin",
      "given": "Erika",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Patrinos",
      "given": "George P.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Mitropoulou",
      "given": "Christina",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "The American Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": true,
    "domain": [
      "ajhg.org",
      "elsevier.com",
      "sciencedirect.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T14:28:56Z",
    "timestamp": 1559226536000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        12,
        6
      ]
    ],
    "date-time": "2019-12-06T02:35:52Z",
    "timestamp": 1575599752000
  },
  "funder": [
    {
      "DOI": "10.13039/501100000780",
      "award": [
        "H2020-668353"
      ],
      "doi-asserted-by": "publisher",
      "name": "European Commission"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        23
      ]
    ],
    "date-time": "2024-03-23T22:04:42Z",
    "timestamp": 1711231482479
  },
  "is-referenced-by-count": 39,
  "issn-type": [
    {
      "type": "print",
      "value": "0002-9297"
    }
  ],
  "issue": "6",
  "issued": {
    "date-parts": [
      [
        2019,
        6
      ]
    ]
  },
  "journal-issue": {
    "issue": "6",
    "published-print": {
      "date-parts": [
        [
          2019,
          6
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            6,
            1
          ]
        ],
        "date-time": "2019-06-01T00:00:00Z",
        "timestamp": 1559347200000
      }
    },
    {
      "URL": "http://www.elsevier.com/open-access/userlicense/1.0/",
      "content-version": "vor",
      "delay-in-days": 188,
      "start": {
        "date-parts": [
          [
            2019,
            12,
            6
          ]
        ],
        "date-time": "2019-12-06T00:00:00Z",
        "timestamp": 1575590400000
      }
    }
  ],
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S000292971930165X?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S000292971930165X?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "member": "78",
  "page": "1158-1168",
  "prefix": "10.1016",
  "published": {
    "date-parts": [
      [
        2019,
        6
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        6
      ]
    ]
  },
  "publisher": "Elsevier BV",
  "reference": [
    {
      "DOI": "10.1016/S0065-2571(00)00011-X",
      "article-title": "Importance of dihydropyrimidine dehydrogenase (DPD) deficiency in patients exhibiting toxicity following treatment with 5-fluorouracil",
      "author": "Johnson",
      "doi-asserted-by": "crossref",
      "first-page": "151",
      "journal-title": "Adv. Enzyme Regul.",
      "key": "10.1016/j.ajhg.2019.04.017_bib1",
      "volume": "41",
      "year": "2001"
    },
    {
      "DOI": "10.1200/JCO.2015.64.2546",
      "article-title": "Is It Finally Time for a personalized medicine approach for Fluorouracil-based therapies?",
      "author": "Offer",
      "doi-asserted-by": "crossref",
      "first-page": "205",
      "journal-title": "J. Clin. Oncol.",
      "key": "10.1016/j.ajhg.2019.04.017_bib2",
      "volume": "34",
      "year": "2016"
    },
    {
      "DOI": "10.1016/S1470-2045(18)30686-7",
      "article-title": "DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis",
      "author": "Henricks",
      "doi-asserted-by": "crossref",
      "first-page": "1459",
      "journal-title": "Lancet Oncol.",
      "key": "10.1016/j.ajhg.2019.04.017_bib3",
      "volume": "19",
      "year": "2018"
    },
    {
      "DOI": "10.1093/jnci/dju298",
      "article-title": "DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147)",
      "author": "Lee",
      "doi-asserted-by": "crossref",
      "first-page": "dju298",
      "journal-title": "J. Natl. Cancer Inst.",
      "key": "10.1016/j.ajhg.2019.04.017_bib4",
      "volume": "106",
      "year": "2014"
    },
    {
      "DOI": "10.1002/ijc.29654",
      "article-title": "Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines",
      "author": "Toffoli",
      "doi-asserted-by": "crossref",
      "first-page": "2971",
      "journal-title": "Int. J. Cancer",
      "key": "10.1016/j.ajhg.2019.04.017_bib5",
      "volume": "137",
      "year": "2015"
    },
    {
      "DOI": "10.1200/JCO.2015.63.1325",
      "article-title": "Upfront genotyping of DPYD∗2A to individualize fluoropyrimidine therapy: A safety and cost analysis",
      "author": "Deenen",
      "doi-asserted-by": "crossref",
      "first-page": "227",
      "journal-title": "J. Clin. Oncol.",
      "key": "10.1016/j.ajhg.2019.04.017_bib6",
      "volume": "34",
      "year": "2016"
    },
    {
      "DOI": "10.1002/cpt.615",
      "article-title": "Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1∗28 Patient Genotype",
      "author": "Roncato",
      "doi-asserted-by": "crossref",
      "first-page": "123",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2019.04.017_bib7",
      "volume": "102",
      "year": "2017"
    },
    {
      "DOI": "10.1002/cpt.1257",
      "doi-asserted-by": "crossref",
      "key": "10.1016/j.ajhg.2019.04.017_bib8",
      "unstructured": "Toffoli, G., Innocenti, F., Polesel, J., et al. The genotype for DPYD risk variants in patients with colorectal cancer and the related toxicity management costs in clinical practice. Clin. Pharmacol. Ther. 105, 994–1002."
    },
    {
      "DOI": "10.1136/bmj.316.7143.1529",
      "article-title": "Perspectives in economic evaluation",
      "author": "Byford",
      "doi-asserted-by": "crossref",
      "first-page": "1529",
      "journal-title": "BMJ",
      "key": "10.1016/j.ajhg.2019.04.017_bib9",
      "volume": "316",
      "year": "1998"
    },
    {
      "DOI": "10.1200/JCO.2005.05.5400",
      "article-title": "The role of UGT1A1∗28 polymorphism in the pharmacodynamics and pharmacokinetics of irinotecan in patients with metastatic colorectal cancer",
      "author": "Toffoli",
      "doi-asserted-by": "crossref",
      "first-page": "3061",
      "journal-title": "J. Clin. Oncol.",
      "key": "10.1016/j.ajhg.2019.04.017_bib10",
      "volume": "24",
      "year": "2006"
    },
    {
      "DOI": "10.1038/tpj.2012.31",
      "article-title": "A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen",
      "author": "Cecchin",
      "doi-asserted-by": "crossref",
      "first-page": "403",
      "journal-title": "Pharmacogenomics J.",
      "key": "10.1016/j.ajhg.2019.04.017_bib11",
      "volume": "13",
      "year": "2013"
    },
    {
      "DOI": "10.1177/0272989X16655341",
      "article-title": "Predicting mean survival time from reported median survival time for cancer patients",
      "author": "Lousdal",
      "doi-asserted-by": "crossref",
      "first-page": "391",
      "journal-title": "Med. Decis. Making",
      "key": "10.1016/j.ajhg.2019.04.017_bib12",
      "volume": "37",
      "year": "2017"
    },
    {
      "DOI": "10.1371/journal.pone.0196007",
      "article-title": "Assessment of costs associated with adverse events in patients with cancer",
      "author": "Wong",
      "doi-asserted-by": "crossref",
      "first-page": "e0196007",
      "journal-title": "PLoS ONE",
      "key": "10.1016/j.ajhg.2019.04.017_bib13",
      "volume": "13",
      "year": "2018"
    },
    {
      "article-title": "Cost implications of reactive versus prospective testing for dihydropyrimidine dehydrogenase deficiency in patients with colorectal cancer: A single-institution experience",
      "author": "Murphy",
      "journal-title": "Dose Resp.",
      "key": "10.1016/j.ajhg.2019.04.017_bib14",
      "volume": "16",
      "year": "2018"
    },
    {
      "DOI": "10.1097/MLR.0b013e31819bc08a",
      "article-title": "Cost analysis with censored data",
      "author": "Huang",
      "doi-asserted-by": "crossref",
      "first-page": "S115",
      "issue": "7, Suppl 1",
      "journal-title": "Med. Care",
      "key": "10.1016/j.ajhg.2019.04.017_bib15",
      "volume": "47",
      "year": "2009"
    },
    {
      "DOI": "10.2147/CEOR.S31552",
      "article-title": "Techniques for estimating health care costs with censored data: an overview for the health services researcher",
      "author": "Wijeysundera",
      "doi-asserted-by": "crossref",
      "first-page": "145",
      "journal-title": "Clinicoecon. Outcomes Res.",
      "key": "10.1016/j.ajhg.2019.04.017_bib16",
      "volume": "4",
      "year": "2012"
    },
    {
      "DOI": "10.1093/biomet/87.2.329",
      "article-title": "Estimating medical costs with censored data",
      "author": "Bang",
      "doi-asserted-by": "crossref",
      "first-page": "329",
      "journal-title": "Biometrika",
      "key": "10.1016/j.ajhg.2019.04.017_bib17",
      "volume": "87",
      "year": "2000"
    },
    {
      "DOI": "10.1258/1355819042250249",
      "article-title": "Multiple regression of cost data: use of generalised linear models",
      "author": "Barber",
      "doi-asserted-by": "crossref",
      "first-page": "197",
      "journal-title": "J. Health Serv. Res. Policy",
      "key": "10.1016/j.ajhg.2019.04.017_bib18",
      "volume": "9",
      "year": "2004"
    },
    {
      "DOI": "10.1186/s12874-017-0445-y",
      "article-title": "Tweedie distributions for fitting semicontinuous health care utilization cost data",
      "author": "Kurz",
      "doi-asserted-by": "crossref",
      "first-page": "171",
      "journal-title": "BMC Med. Res. Methodol.",
      "key": "10.1016/j.ajhg.2019.04.017_bib19",
      "volume": "17",
      "year": "2017"
    },
    {
      "DOI": "10.1002/sim.1377",
      "article-title": "Regression analysis of incomplete medical cost data",
      "author": "Lin",
      "doi-asserted-by": "crossref",
      "first-page": "1181",
      "journal-title": "Stat. Med.",
      "key": "10.1016/j.ajhg.2019.04.017_bib20",
      "volume": "22",
      "year": "2003"
    },
    {
      "DOI": "10.1093/qjmed/92.3.177",
      "article-title": "Bootstrapping: estimating confidence intervals for cost-effectiveness ratios",
      "author": "Campbell",
      "doi-asserted-by": "crossref",
      "first-page": "177",
      "journal-title": "QJM",
      "key": "10.1016/j.ajhg.2019.04.017_bib21",
      "volume": "92",
      "year": "1999"
    },
    {
      "DOI": "10.1177/0272989X12470755",
      "article-title": "Cost-effectiveness of adjuvant FOLFOX and 5FU/LV chemotherapy for patients with stage II colon cancer",
      "author": "Ayvaci",
      "doi-asserted-by": "crossref",
      "first-page": "521",
      "journal-title": "Med. Decis. Making",
      "key": "10.1016/j.ajhg.2019.04.017_bib22",
      "volume": "33",
      "year": "2013"
    },
    {
      "DOI": "10.1186/s12955-018-0994-8",
      "article-title": "Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients",
      "author": "Paracha",
      "doi-asserted-by": "crossref",
      "first-page": "179",
      "journal-title": "Health Qual. Life Outcomes",
      "key": "10.1016/j.ajhg.2019.04.017_bib23",
      "volume": "16",
      "year": "2018"
    },
    {
      "DOI": "10.1371/journal.pone.0169401",
      "article-title": "Cost-Effectiveness of Treating Hepatitis C with Sofosbuvir/Ledipasvir in Germany",
      "author": "Stahmeyer",
      "doi-asserted-by": "crossref",
      "first-page": "e0169401",
      "journal-title": "PLoS ONE",
      "key": "10.1016/j.ajhg.2019.04.017_bib24",
      "volume": "12",
      "year": "2017"
    },
    {
      "DOI": "10.1111/j.1524-6175.2002.00970.x",
      "article-title": "The quality of life of patients with hypertension",
      "author": "Stein",
      "doi-asserted-by": "crossref",
      "first-page": "181",
      "journal-title": "J. Clin. Hypertens. (Greenwich)",
      "key": "10.1016/j.ajhg.2019.04.017_bib25",
      "volume": "4",
      "year": "2002"
    },
    {
      "DOI": "10.1038/sj.bjc.6603326",
      "article-title": "Health state utilities for metastatic breast cancer",
      "author": "Lloyd",
      "doi-asserted-by": "crossref",
      "first-page": "683",
      "journal-title": "Br. J. Cancer",
      "key": "10.1016/j.ajhg.2019.04.017_bib26",
      "volume": "95",
      "year": "2006"
    },
    {
      "DOI": "10.1080/14737167.2016.1190644",
      "article-title": "Health utility of patients with Crohn’s disease and ulcerative colitis: a systematic review and meta-analysis",
      "author": "Malinowski",
      "doi-asserted-by": "crossref",
      "first-page": "441",
      "journal-title": "Expert Rev. Pharmacoecon. Outcomes Res.",
      "key": "10.1016/j.ajhg.2019.04.017_bib27",
      "volume": "16",
      "year": "2016"
    },
    {
      "DOI": "10.1634/theoncologist.6-5-441",
      "article-title": "Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients",
      "author": "Calhoun",
      "doi-asserted-by": "crossref",
      "first-page": "441",
      "journal-title": "Oncologist",
      "key": "10.1016/j.ajhg.2019.04.017_bib28",
      "volume": "6",
      "year": "2001"
    },
    {
      "DOI": "10.1038/tpj.2016.34",
      "article-title": "Assessment of pharmacogenetic tests: presenting measures of clinical validity and potential population impact in association studies",
      "author": "Tonk",
      "doi-asserted-by": "crossref",
      "first-page": "386",
      "journal-title": "Pharmacogenomics J.",
      "key": "10.1016/j.ajhg.2019.04.017_bib29",
      "volume": "17",
      "year": "2017"
    },
    {
      "DOI": "10.1002/cpt.1049",
      "article-title": "Pharmacogenetic Information in Clinical Guidelines: The European Perspective",
      "author": "Swen",
      "doi-asserted-by": "crossref",
      "first-page": "795",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2019.04.017_bib30",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.2217/pgs-2017-0300",
      "article-title": "Rare disease prevention and treatment: the need for a level playing field",
      "author": "Hughes",
      "doi-asserted-by": "crossref",
      "first-page": "243",
      "journal-title": "Pharmacogenomics",
      "key": "10.1016/j.ajhg.2019.04.017_bib31",
      "volume": "19",
      "year": "2018"
    },
    {
      "DOI": "10.2217/pgs-2016-0006",
      "article-title": "Cost-effectiveness of screening for DPYD polymorphisms to prevent neutropenia in cancer patients treated with fluoropyrimidines",
      "author": "Cortejoso",
      "doi-asserted-by": "crossref",
      "first-page": "979",
      "journal-title": "Pharmacogenomics",
      "key": "10.1016/j.ajhg.2019.04.017_bib32",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ejca.2018.11.010",
      "article-title": "A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy",
      "author": "Henricks",
      "doi-asserted-by": "crossref",
      "first-page": "60",
      "journal-title": "Eur. J. Cancer",
      "key": "10.1016/j.ajhg.2019.04.017_bib33",
      "volume": "107",
      "year": "2019"
    },
    {
      "DOI": "10.1177/0272989X14536779",
      "article-title": "A Review and Meta-analysis of Colorectal Cancer Utilities",
      "author": "Djalalov",
      "doi-asserted-by": "crossref",
      "first-page": "809",
      "journal-title": "Med. Decis. Making",
      "key": "10.1016/j.ajhg.2019.04.017_bib34",
      "volume": "34",
      "year": "2014"
    }
  ],
  "reference-count": 34,
  "references-count": 34,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S000292971930165X"
    }
  },
  "score": 0,
  "short-container-title": [
    "The American Journal of Human Genetics"
  ],
  "source": "Crossref",
  "title": [
    "Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy",
  "volume": "104"
}